XML 56 R39.htm IDEA: XBRL DOCUMENT
v3.24.1

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Segment Reporting [Abstract] |
Schedule of Operations by Reportable Segment | Approximate information concerning the Company’s operations by reportable segment for the twelve months ended December 31, 2023 and 2022 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Schedule of Operations by Reportable Segment
Year Ended December 31, 2023 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct Marketing |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 18,497,000 |  |  | $ | 385,000 |  |  | $ | 6,088,000 |  |  | $ | - |  |  | $ | 5,288,000 |  |  | $ | - |  |  | $ | 30,258,000 |
Assets held for sale |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 51,595,000 |  |  |  | - |  |  |  | 51,595,000 |
Depreciation and amortization |  |  | 761,000 |  |  |  | - |  |  |  | 157,000 |  |  |  | 1,163,000 |  |  |  | 3,047,000 |  |  |  | 78,000 |  |  |  | 5,206,000 |
Cost of revenue |  |  | 15,282,000 |  |  |  | 1,139,000 |  |  |  | 2,075,000 |  |  |  | 77,000 |  |  |  | 8,003,000 |  |  |  | 71,000 |  |  |  | 26,647,000 |
Interest expense |  |  | 185,000 |  |  |  | - |  |  |  | (5,000 | ) |  |  | - |  |  |  | 4,632,000 |  |  |  | - |  |  |  | 4,812,000 |
Interest Income |  |  | - |  |  |  | - |  |  |  | 986,000 |  |  |  | 155,000 |  |  |  | 148,000 |  |  |  | - |  |  |  | 1,289,000 |
Stock based compensation |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Net income (loss) from continuing operations |  |  | 327,000 |  |  |  | (31,497,000 | ) |  |  | (32,860,000 | ) |  |  | (7,168,000 | ) |  |  | (19,792,000 | ) |  |  | (6,513,000 | ) |  |  | (97,503,000 | )
Capital expenditures |  |  | 689,000 |  |  |  | - |  |  |  | 4,000 |  |  |  | 17,000 |  |  |  | 104,000 |  |  |  | 4,000 |  |  |  | 818,000 |
Identifiable assets |  |  | 21,508,000 |  |  |  | 12,285,000 |  |  |  | 6,303,000 |  |  |  | 49,305,000 |  |  |  | 59,345,000 |  |  |  | 4,446,000 |  |  |  | 153,192,000 |
Year Ended December 31,2022 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 17,973,000 |  |  | $ | 764,000 |  |  | $ | 21,989,000 |  |  | $ | - |  |  | $ | 6,581,000 |  |  | $ | - |  |  | $ | 47,307,000 |
Depreciation and amortization |  |  | 715,000 |  |  |  | - |  |  |  | 413,000 |  |  |  | 1,113,000 |  |  |  | 9,093,000 |  |  |  | 129,000 |  |  |  | 11,463,000 |
Cost of revenue |  |  | 16,960,000 |  |  |  | 1,041,000 |  |  |  | 9,828,000 |  |  |  | - |  |  |  | 11,784,000 |  |  |  | 634,000 |  |  |  | 40,247,000 |
Interest expense |  |  | 140,000 |  |  |  | - |  |  |  | 1,000 |  |  |  | - |  |  |  | (15,000 | ) |  |  | - |  |  |  | 126,000 |
Stock based compensation |  |  | 1,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 3,000 |  |  |  | 4,000 |
Net income (loss) from continuing operations |  |  | (1,234,000 | ) |  |  | (459,000 | ) |  |  | (40,182,000 | ) |  |  | (7,462,000 | ) |  |  | (8,238,000 | ) |  |  | (12,084,000 | ) |  |  | (69,662,000 | )
Capital expenditures |  |  | 1,612,000 |  |  |  | - |  |  |  | 384,000 |  |  |  | 276,000 |  |  |  | 18,000 |  |  |  | 4,000 |  |  |  | 2,294,000 |
Identifiable assets |  |  | 24,641,000 |  |  |  | 48,240,000 |  |  |  | 27,526,000 |  |  |  | 53,069,000 |  |  |  | 83,873,000 |  |  |  | 11,566,000 |  |  |  | 248,915,000 |
Schedule of Disaggregation of Revenue | Printed Products Revenue Information: Schedule of Disaggregation of Revenue
Twelve months ended December 31, 2023 |  |  |
Packaging Printing and Fabrication |  | $ | 18,036,000 |
Commercial and Security Printing |  |  | 461,000 |
Total Printed Products |  | $ | 18,497,000 |
Twelve months ended December 31, 2022 |  |  |
Packaging Printing and Fabrication |  | $ | 17,499,000 |
Commercial and Security Printing |  |  | 474,000 |
Total Printed Products |  | $ | 17,973,000 |
Direct Marketing
Twelve months ended December 31, 2023 |  |  |
Direct Marketing Internet Sales |  | $ | 6,088,000 |
Total Direct Marketing |  | $ | 6,088,000 |
Twelve months ended December 31, 2022 |  |  |
Direct Marketing Internet Sales |  | $ | 21,989,000 |
Total Direct Marketing |  | $ | 21,989,000 |
Rental Income
Twelve months ended December 31, 2023 |  |  |
Rental income |  | $ | 3,647,000 |
Total Rental Income |  | $ | 3,647,000 |
Twelve months ended December 31, 2022 |  |  |
Rental income |  | $ | 6,287,000 |
Total Rental Income |  | $ | 6,287,000 |
Commission Income
Twelve months ended December 31, 2023 |  |  |
Commission income |  | $ | 1,641,000 |
Total commission income |  | $ | 1,641,000 |
Twelve months ended December 31, 2022 |  |  |
Commission income |  | $ | 294,000 |
Total commission income |  | $ | 294,000 |
Management Fee Income
Twelve months ended December 31, 2023 |  |  |
Management fee income |  | $ | - |
Total Management fee income |  | $ | - |
Twelve months ended December 31, 2022 |  |  |
Management fee income |  | $ | 134,000 |
Total Management fee income |  | $ | 134,000 |
Net Investment Income
Twelve months ended December 31, 2023 |  |  |
Net investment income |  | $ | 385,000 |
Total Net Investment Income |  | $ | 385,000 |
Twelve months ended December 31, 2022 |  |  |
Net investment income |  | $ | 630,000 |
Total Net Investment Income |  | $ | 630,000 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration